A recent study indicates that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end traditional lifestyle regimens.
Published data in a prominent health publication shows that while obese individuals can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Individuals using such medications must be aware of the potential of quick rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight in about 18 months.
Analyzing Approaches
The study, which looked at 37 of studies involving over 9,000 of participants, compared the outcomes of these new drugs with older methods.
Scientists emphasize that people who shed pounds through dieting usually have a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Rapid Regain
Doctors believe the mode of action of the injections accounts for the amplified weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication results in appetite is no longer kept in check, making overeating far more likely."
An Ongoing Disease?
The NHS advise the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts contend that, given the likelihood of relapse, the therapy should be considered ongoing.
This perspective is reinforced by pharmaceutical companies, who state that the results "underscore the long-term character of obesity," akin to managing diseases like diabetes.
Patient Testimonies
Users who have come off the jabs explain a intense resurgence of hunger.
"It was like a switch activating and you're instantly starving," recalled a patient.
This difficulty is exacerbated if individuals have not established sustainable lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates show that a significant number of people in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, researchers stress that while the jabs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits relies on ongoing behavioural support.